Althea signs supply pact with Biotest
As per the terms of the agreement, Althea will act as a commercial filler for Biotest Pharma and will fill commercial drug products of Biotest Pharma to supply
Biologics contract development and manufacturing organisation (CDMO) AsymBio is set to secure 1.2397bn yuan (approximately $184m) from Asymchem Group, Hillhouse Qirui and other investors to support its long-term growth.